HighTower Advisors
CRBU icon

HighTower Advisors’s Caribou Biosciences CRBU Stock Holding History

HighTower Advisors’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.8K Hold
16,934
– – ﹤0.01% 3754
2026
Q1 		$32.2K Hold
16,934
– – ﹤0.01% 3739
2025
Q4 		$26.9K Hold
16,934
– – ﹤0.01% 3602
2025
Q3 		$39.5K Sell
16,934
-200
-1% -$378 ﹤0.01% 3625
2025
Q2 		$21.6K Buy
17,134
+3,917
+30% +$3.85K ﹤0.01% 3612
2025
Q1 		$12.1K Buy
13,217
+296
+2% +$385 ﹤0.01% 3550
2024
Q4 		$20.5K Buy
+12,921
New +$26K ﹤0.01% 3541

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

HighTower Advisors's CRBU Position: Q2 2026 in Review

HighTower Advisors held its Caribou Biosciences (CRBU) position steady in Q2 2026 at 16,934 shares worth $29.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3754.

HighTower Advisors first reported a position in CRBU in Q4 2024 and has held it in 7 quarters since. The position peaked at $39.5K in Q3 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • HighTower Advisors held 16,934 shares of Caribou Biosciences worth $29.8K as of Q2 2026.
  • HighTower Advisors left its Caribou Biosciences share count unchanged in Q2 2026.
  • Caribou Biosciences made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3754 holding.
  • HighTower Advisors first reported a position in Caribou Biosciences in Q4 2024 and has held it in 7 quarters since.
  • HighTower Advisors's Caribou Biosciences position peaked at $39.5K in Q3 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.